(Q42978401)

12 November 2017

Insulin resistance and diabetes increase fibrosis in the liver of patients with genotype 1 HCV infection (English)

1 reference

12 November 2017

1 reference

1

1 reference

12 November 2017

11

1 reference

12 November 2017

Giulio Marchesini

10

0 references

Anna Licata

object named as

Anna Licata

7

0 references

Daniela Cabibi

5

object named as

Daniela Cabibi

0 references

Calogero Cammà

2

object named as

Calogero Cammà

1 reference

12 November 2017

4

Nicola Alessi

1 reference

12 November 2017

6

Rosalia Caldarella

1 reference

12 November 2017

Vito Di Marco

3

1 reference

12 November 2017

Fatima Massenti

8

1 reference

12 November 2017

Giuseppe Tarantino

9

1 reference

12 November 2017

language of work or name

English

0 references

publication date

1 May 2008

1 reference

The American Journal of Gastroenterology

12 November 2017

1 reference

12 November 2017

103

1 reference

12 November 2017

1136-1144

1 reference

12 November 2017

5

1 reference

Hepatitis viruses: live and let die.

12 November 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2008.01813.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2008.01813.X

Insulin resistance: a metabolic pathway to chronic liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2008.01813.X

Hepatitis C virus: the viral way to fatty liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2008.01813.X

Insulin resistance is associated with steatosis in nondiabetic patients with genotype 1 chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2008.01813.X

Insulin resistance plays a significant role in liver fibrosis in chronic hepatitis C and in the response to antiviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2008.01813.X

Insulin resistance is associated with liver fibrosis in non-diabetic chronic hepatitis C patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2008.01813.X

Association between liver fibrosis and insulin sensitivity in chronic hepatitis C patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2008.01813.X

Fibrosis in genotype 3 chronic hepatitis C and nonalcoholic fatty liver disease: Role of insulin resistance and hepatic steatosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2008.01813.X

Improved prediction of fibrosis in chronic hepatitis C using measures of insulin resistance in a probability index

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2008.01813.X

Insulin resistance is associated with chronic hepatitis C virus infection and fibrosis progression [corrected].

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2008.01813.X

Insulin resistance impairs sustained response rate to peginterferon plus ribavirin in chronic hepatitis C patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2008.01813.X

Hepatitis C virus genotype 3 is cytopathic to hepatocytes: Reversal of hepatic steatosis after sustained therapeutic response

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2008.01813.X

High glucose and hyperinsulinemia stimulate connective tissue growth factor expression: a potential mechanism involved in progression to fibrosis in nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2008.01813.X

Hepatitis C virus infection and incident type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2008.01813.X

Chronic hepatitis C and type II diabetes mellitus: a prospective cross-sectional study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2008.01813.X

Hepatogenous diabetes: reduced insulin sensitivity and increased awareness.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2008.01813.X

Hepatitis C virus infection and diabetes: direct involvement of the virus in the development of insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2008.01813.X

Fibrogenic impact of high serum glucose in chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2008.01813.X

Contribution of obesity to hepatitis C-related fibrosis progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2008.01813.X

Chronic hepatitis C and superimposed nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2008.01813.X

Treatment of hepatitis C: critical appraisal of the evidence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2008.01813.X

Fibrosis progression in initially mild chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2008.01813.X

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2008.01813.X

Clinical significance of the insulin resistance index as assessed by homeostasis model assessment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2008.01813.X

Plasma adiponectin in nonalcoholic fatty liver is related to hepatic insulin resistance and hepatic fat content, not to liver disease severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2008.01813.X

Impact of liver biopsy size on histological evaluation of chronic viral hepatitis: the smaller the sample, the milder the disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2008.01813.X

Classification of chronic viral hepatitis: a need for reassessment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2008.01813.X

Daily cannabis smoking as a risk factor for progression of fibrosis in chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2008.01813.X

Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2008.01813.X

Worsening of steatosis is an independent factor of fibrosis progression in untreated patients with chronic hepatitis C and paired liver biopsies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2008.01813.X

The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2008.01813.X

Endemic hepatitis C virus infection in a Sicilian town: further evidence for iatrogenic transmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2008.01813.X

Slow glucose removal rate and hyperinsulinemia precede the development of type II diabetes in the offspring of diabetic parents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2008.01813.X

The metabolic syndrome, hyperlipidemia, and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2008.01813.X

Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2008.01813.X

Blood lipids of patients with chronic hepatitis: differences related to viral etiology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2008.01813.X

Serum lipid pattern in chronic hepatitis C: histological and virological correlations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2008.01813.X

Clinical significance of hepatic iron deposition and serum iron values in patients with chronic hepatitis C infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2008.01813.X

Progression of fibrosis in chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2008.01813.X

Sequential algorithms combining non-invasive markers and biopsy for the assessment of liver fibrosis in chronic hepatitis B

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2008.01813.X

The utility of radiological imaging in nonalcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2008.01813.X

10.1111/J.1572-0241.2008.01813.X

21 January 2018

Identifiers

DOI

1 reference

12 November 2017

1 reference